Aflibercept 13 September 2024 | KR | Alteogen Submits Application for Biosimilar Aflibercept in Korea On 13 September...
Pearce IP BioBlast® for the week ending 13 September 2024
read more
Pearce IP BioBlast® for the fortnight ending 06 September 2024
Adalimumab 1 September 2024 | AU | Pfizer’s Biosimilar Adalimumab PBS-Listed in Australia On 1 September 2024, the PBS...
Pearce IP BioBlast® for w/e 16 August 2024
16 August 2024 | AU | Janssen Sues Samsung Bioepis for Patent Infringement in Australian Court On 16 August 2024,...
Pearce IP BioBlast® for w/e 09 August 2024
9 August 2024 | Sandoz Reports Q2/24 and Half Year Financial Results - 37% Biosimilar Growth On 9 August 2024, Sandoz...
Patent Opposition Fails to Block Patent Term Extension for COPD and Asthma Drug
CQMS Triumphs in Patent Opposition Against ESCO Group